5481 - 5490 of 6295 Results
Title
Year
-
OPENTitle: NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse PopulationsJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 11Start Page: 2039End Page: 2048Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29902Best OA location URL: https://doi.org/10.1002/mds.29902Citation Count: 16
-
OPENTitle: Pharmacological Inhibition of PTEN Rescues Dopaminergic Neurons by Attenuating Apoptotic and Neuroinflammatory Signaling EventsJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 3Start Page: 462End Page: 475Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11481-023-10077-8Best OA location URL: https://www.researchsquare.com/article/rs-1785484/latest.pdfCitation Count: 5
-
OPENTitle: Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 5Issue #:Start Page: 100113End Page: 100113Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100113Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100113Citation Count: 12
-
OPENTitle: Simulations predict differing phase responses to excitation vs. inhibition in theta-resonant pyramidal neuronsJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 130Issue #: 4Start Page: 910End Page: 924Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1152/jn.00160.2023Best OA location URL: https://doi.org/10.1152/jn.00160.2023Citation Count: 1
-
OPENTitle: R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophilsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 142Issue #: 3Start Page: 475End Page: 494Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02325-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02325-z.pdfCitation Count: 54
-
OPENTitle: Remote Digital Monitoring for Medical Product DevelopmentJournal Name: Clinical and Translational SciencePublisher: WileyVol: 14Issue #: 1Start Page: 94End Page: 101Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/cts.12851Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.12851Citation Count: 19
-
OPENTitle: Seed amplification assay results illustrate discrepancy in Parkinson’s disease clinical diagnostic accuracy and error ratesJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 270Issue #: 12Start Page: 5813End Page: 5818Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-023-11810-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-023-11810-2.pdfCitation Count: 6
-
OPENTitle: Dietary antioxidants associated with slower progression of parkinsonian signs in older adultsJournal Name: Nutritional NeurosciencePublisher: Informa UK LimitedVol: 25Issue #: 3Start Page: 550End Page: 557Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/1028415x.2020.1769411Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7680274Citation Count: 25
-
OPENTitle: Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2020Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/4981647Best OA location URL: https://downloads.hindawi.com/journals/pd/2020/4981647.pdfCitation Count: 12
-
OPENTitle: Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementiaJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-021-00892-7Best OA location URL: https://doi.org/10.1186/s13195-021-00892-7Citation Count: 20